https://www.biotechblueprint.com/p/mercks-13b-eye-drug-loses-to-a-20Biotech Blueprinten2026-10-16T11:45:44+00:00Merck paid $1.3B for a drug that ties an older rival and looks worse on safety – This Week in Biotech #122